Two Sigma Securities’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
Other funds holding PRLD
BBA
KCM
Two Sigma Securities's PRLD Position: Q3 2026 in Review
Two Sigma Securities opened a new position in Prelude Therapeutics (PRLD) in Q3 2026: 12,793 shares worth $50K. The stake represents ﹤0.01% of the portfolio and ranks #1407 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in PRLD as recently as Q1 2023.
Two Sigma Securities first reported a position in PRLD in Q1 2023 and has held it in 2 quarters since. The position peaked at $62.3K in Q1 2023. 92 funds tracked by Wall St. Rank hold PRLD as of Q3 2026.
- Two Sigma Securities held 12,793 shares of Prelude Therapeutics worth $50K as of Q3 2026.
- Prelude Therapeutics was a new Two Sigma Securities position in Q3 2026.
- Prelude Therapeutics made up ﹤0.01% of Two Sigma Securities's portfolio in Q3 2026, its #1407 holding.
- Two Sigma Securities first reported a position in Prelude Therapeutics in Q1 2023 and has held it in 2 quarters since.
- Two Sigma Securities's Prelude Therapeutics position peaked at $62.3K in Q1 2023.
- 92 funds tracked by Wall St. Rank held Prelude Therapeutics as of Q3 2026.
Based on Two Sigma Securities's 13F filing for Q3 2026, filed 16 Nov 2026.